References
- Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography (18F-FET PET) in glioblastoma surgery. Neurol Res. 2012;34:314–7.
- Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003–13.
- Floeth FW, Sabel M, Ewelt C, Stummer W, Felsberg J, Reifenberger G, et al.. Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging. 2011;38:731–41.
- Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology. 1988;38:1371–4.
- Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol. 1998;49:436–40.
- Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, et al.. Prognostic value of O-(2-18F-fluoroethyl)-l-tyrosine PET and MRI in low-grade glioma. J Nucl Med. 2007;48:519–27.
- Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, et al.. German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids. Nuklearmedizin. 2011;50:167–73.
- Stockhammer F, Misch M, Horn P, Koch A, Fonyuy N, Plotkin M. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Acta Neurochir (Wien). 2009;151:1377–83.
- Rapp M, Heinzel A, Galldiks N, et al.. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suspicious for glioma. J Nucl Med. 2012; to be published J Nucl Med. 2012 Dec 11. [Epub ahead of print] PubMed PMID: 23232275.
- Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, et al.. O-(2-[18F]fluorethyl)-l-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging. 2005;32:422–9.
- Pöpperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, et al.. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 2007;34:1933–42.
- Utsuki S, Oka H, Sato S, Shimizu S, Suzuki S, Tanizaki Y, et al.. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo). 2007;47:210–3; discussion 213–4.